Contrast Media Agents Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Contrast Media Agents Market by Product Type (Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media), By Modality (X-Ray, CT-Scan, Magnetic Resonance Imaging (MRI), Ultrasound, Others), By Route of Administration (Oral Contrast Media, Injectable Contrast Media, Rectal Contrast Media, Urethral Contrast Media, Others), By Disease Indication (Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders, Cardiovascular Disorders, Oncology, Gastrointestinal Disorders), By Application (Radiology, Interventional Radiology, Interventional Cardiology), By End User (Hospitals, Clinics, Diagnostic Centers, Others), and Geography.

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Categories: Healthcare, Pharmaceuticals

Description
Table Of Content
Company Profile

Report

Description

Contrast media agents market size was valued at USD 5.1 billion in 2021, It is excepted to reach USD 6.76 billion by 2028 at a CAGR of 4.1% from 2022-2028. Contrast media agents market report gives a comprehensive outlook on contrast media agents across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global contrast media agents market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, modality, route of administration, disease indication, application, end user, and region. This report studies global contrast media agents market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. Contrast media agents market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global contrast media agents market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Contrast media agents market is poised to grow significantly due to increase in prevalence of chronic diseases such as cardiovascular disorders, respiratory disorders, and other chronic diseases around the globe. Moreover, rise in R&D for the development of newer contrast media agents, rise in demand for diagnostic imaging modalities such CT-scan and MRI, and favorable reimbursement policies for diagnostic procedures are the major factors that are driving the growth of the market. The market is surging owing to frequent product approvals and launchings by the market players. For instance, In March 2017, GE Healthcare expands MRI contrast media product range in Europe with launch of macrocyclic agent Clariscan a gadolinium-based contrast agent (GBCA) designed to support effective visualisation of abnormalities in the brain, spine and associated tissues.

Contrast Media Agents Market

MARKET SUMMARY

4.1% CAGR

Study Period– 2022 – 2028
Base Year– 2021
CAGR– 4.1%
Largest Market– North America
Fastest Growing Market– Asia Pacific

Contrast Media Agents Market

Global contrast media agents market expanding at significant CAGR over 2022 to 2028 owing to increase in the prevalence of chronic diseases around the globe.
Based on disease indication, cardiovascular diseases accounted for larger market revenue share in 2018 and projected gain market revenue share over the forecast period
Players focusing on innovation of newer products and collaboration strategies to retain market position in global contrast media agents market
Moreover, rise in R&D for the development of newer contrast media agents, rise in demand for diagnostic imaging modalities such CT-scan and MRI, and favorable reimbursement policies for diagnostic procedures are the major factors that are driving the growth of the contrast media agents market.
Moreover, in February 2016, Bracco Imaging received FDA approval for the barium-based contrast agent in the U.S.

Market Key Players

GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India

Contrast Media Agents Market Drivers and Restraints

Increase in the prevalence of chronic diseases such as cardiovascular and respiratory disorders are anticipated to fuel the contrast media agents market over the forecast years. For instance, according to WHO, approximately 17.9 Mn deaths occurred due to cardiovascular disorders around the globe. Moreover, rise in awareness about the chronic diseases, sophisticated healthcare infrastructure in developed and developing countries, increase in healthcare expenditure, and technological advancements in the medical guided imaging techniques are anticipated to bolster the market over the forecast timeframe.

North-America Got Significant Share

Contrast Media Agents Market

North America accounted for larger revenue share in global contrast media agents market with significant CAGR. Increase in prevalence of chronic diseases coupled with grow in adoption of medical imaging testing procedures, favorable reimbursement policies, and rise in healthcare expenditure are anticipated to propel the market in North America region. Asia Pacific contrast media agents market projected to grow at significant rate owing to increase in medical tourism in India and China, development in healthcare infrastructure, and surge in prevalence of cardiovascular diseases and other chronic diseases are expected to enhance the market over the forecast years.

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup’s details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Contrast Media Agents Market Segmentation

Product-Application

Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Radiology
Interventional Radiology
Interventional Cardiology

Modality-End-User

X-Ray
CT-Scan
Magnetic Resonance Imaging (MRI)
Ultrasound
Hospitals
Clinics
Diagnostic Centers

Route-Administration

Oral Contrast Media
Injectable Contrast Media
Rectal Contrast Media
Urethral Contrast Media
Others

Disease-Indication

Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Cardiovascular Disorders
Oncology
Gastrointestinal Disorders

Location

GEOGRAPHY

Frequently Asked Questions

The contrast media agents market is projected to expand at a CAGR of 4.1% during the forecast period.

GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany) Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India

North America is the fastest-growing region for the contrast media agents market

Report

Table Of Content

1. Executive Summary

2. Global Contrast Media Agents Market Introduction

2.1. Global Contrast Media Agents Market – Taxonomy

2.2. Global Contrast Media Agents Market –Definitions

2.2.1. By Product Type

2.2.2. By Modality

2.2.3. By Route of Administration

2.2.4. By Disease Indication

2.2.5. By Application

3. Global Contrast Media Agents Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Contrast Media Agents Market Dynamics – Factors Impact Analysis

3.6. Global Contrast Media Agents Market – Competition Landscape

4. Global Contrast Media Agents Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Contrast Media Agents Market Forecast, By Product Type , 2014 – 2018 and Forecast, 2019 – 2025

5.1. Barium-based Contrast Media

5.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Iodinated Contrast Media

5.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Gadolinum-based Contrast Media

5.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

5.4. Microbubble Contrast Media

5.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

6. Global Contrast Media Agents Market Forecast, By Modality, 2014 – 2018 and Forecast, 2019 – 2025

6.1. X-Ray

6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. CT-Scan

6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Magnetic Resonance Imaging

6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Ultrasound

6.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Others

6.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

7. Global Contrast Media Agents Market Forecast, By Route of Administration, 2014 – 2018 and Forecast, 2019 – 2025

7.1. Oral

7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Injectable

7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Rectal

7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Urethral

7.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. Others

7.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

8. Global Contrast Media Agents Market Forecast, By Disease Indication, 2014 – 2018 and Forecast, 2019 – 2025

8.1. Musculoskeletal Disorders

8.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Neurological Disorders

8.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Nephrological Disorders

8.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Cardiovascular Disorders

8.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Oncology

8.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Gastrointestinal Disorders

8.6.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.6.3. Market Opportunity Analysis

9. Global Contrast Media Agents Market Forecast, By Application, 2014 – 2018 and Forecast, 2019 – 2025

9.1. Radiology

9.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Interventional Radiology

9.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Interventional Cardiology

9.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

10. Global Contrast Media Agents Market Forecast, By End User, 2014 – 2018 and Forecast, 2019 – 2025

10.1. Hospitals

10.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

10.1.3. Market Opportunity Analysis

10.2. Clinics

10.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

10.2.3. Market Opportunity Analysis

10.3. Diagnostic Centers

10.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

10.3.3. Market Opportunity Analysis

10.4. Others

10.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

10.4.3. Market Opportunity Analysis

11. Global Contrast Media Agents Market Forecast, By Region, 2014 – 2018 and Forecast, 2019 – 2025

11.1. North America

11.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

11.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

11.1.3. Market Opportunity Analysis

11.2. Europe

11.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

11.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

11.2.3. Market Opportunity Analysis

11.3. Asia Pacific

11.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

11.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

11.3.3. Market Opportunity Analysis

11.4. Latin America

11.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

11.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

11.4.3. Market Opportunity Analysis

11.5. The Middle East & Africa

11.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn)

11.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

11.5.3. Market Opportunity Analysis

11.6. Global Contrast Media Agents Market – Opportunity Analysis Index, By Product Type, By Modality, By Route of Administration, By Disease Indication, By Application, By End User, and Region, 2019 – 2025

12. North America Contrast Media Agents Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

12.1. Product Type Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Barium-based Contrast Media

12.1.2. Iodinated Contrast Media

12.1.3. Gadolinium-based Contrast Media

12.1.4. Microbubble Contrast Media

12.2. Modality Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. X-Ray

12.2.2. CT-Scan

12.2.3. Magnetic Resonance Imaging (MRI)

12.2.4. Ultrasound

12.2.5. Others

12.3. Route of Administration Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.3.1. Oral

12.3.2. Injectable

12.3.3. Rectal

12.3.4. Urethral

12.3.5. Others

12.4. Disease Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.4.1. Musculoskeletal Disorders

12.4.2. Neurological Disorders

12.4.3. Nephrological Disorders

12.4.4. Cardiovascular Disorders

12.4.5. Oncology

12.4.6. Gastrointestinal Disorders

12.5. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.5.1. Radiology

12.5.2. Interventional Radiology

12.5.3. Interventional Cardiology

12.6. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.6.1. Hospitals

12.6.2. Clinics

12.6.3. Diagnostic Centers

12.6.4. Others

12.7. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.7.1. U.S.

12.7.2. Canada

12.8. North America Contrast Media Agents Market – Opportunity Analysis Index, By Product Type, By Modality, By Route of Administration, By Disease Indication, By Application, By End User, and Country, 2019 – 2025

12.9. North America Contrast Media Agents Market Dynamics – Trends

13. Europe Contrast Media Agents Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

13.1. Product Type Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.1.1. Barium-based Contrast Media

13.1.2. Iodinated Contrast Media

13.1.3. Gadolinium-based Contrast Media

13.1.4. Microbubble Contrast Media

13.2. Modality Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.2.1. X-Ray

13.2.2. CT-Scan

13.2.3. Magnetic Resonance Imaging (MRI)

13.2.4. Ultrasound

13.2.5. Others

13.3. Route of Administration Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.3.1. Oral

13.3.2. Injectable

13.3.3. Rectal

13.3.4. Urethral

13.3.5. Others

13.4. Disease Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.4.1. Musculoskeletal Disorders

13.4.2. Neurological Disorders

13.4.3. Nephrological Disorders

13.4.4. Cardiovascular Disorders

13.4.5. Oncology

13.4.6. Gastrointestinal Disorders

13.5. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.5.1. Radiology

13.5.2. Interventional Radiology

13.5.3. Interventional Cardiology

13.6. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

13.6.1. Hospitals

13.6.2. Clinics

13.6.3. Diagnostic Centers

13.6.4. Others

13.7. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.7.1. Germany

13.7.2. UK

13.7.3. France

13.7.4. Spain

13.7.5. Italy

13.7.6. Russia

13.7.7. Poland

13.7.8. Rest of Europe

13.8. Europe Contrast Media Agents Market – Opportunity Analysis Index, By Product Type, By Modality, By Route of Administration, By Disease Indication, By Application, By End User, and Country, 2019 – 2025

13.9. Europe Contrast Media Agents Market Dynamics – Trends

14. Asia Pacific Contrast Media Agents Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

14.1. Product Type Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.1.1. Barium-based Contrast Media

14.1.2. Iodinated Contrast Media

14.1.3. Gadolinium-based Contrast Media

14.1.4. Microbubble Contrast Media

14.2. Modality Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.2.1. X-Ray

14.2.2. CT-Scan

14.2.3. Magnetic Resonance Imaging (MRI)

14.2.4. Ultrasound

14.2.5. Others

14.3. Route of Administration Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.3.1. Oral

14.3.2. Injectable

14.3.3. Rectal

14.3.4. Urethral

14.3.5. Others

14.4. Disease Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.4.1. Musculoskeletal Disorders

14.4.2. Neurological Disorders

14.4.3. Nephrological Disorders

14.4.4. Cardiovascular Disorders

14.4.5. Oncology

14.4.6. Gastrointestinal Disorders

14.5. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.5.1. Radiology

14.5.2. Interventional Radiology

14.5.3. Interventional Cardiology

14.6. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

14.6.1. Hospitals

14.6.2. Clinics

14.6.3. Diagnostic Centers

14.6.4. Others

14.7. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

14.7.1. Japan

14.7.2. China

14.7.3. India

14.7.4. ASEAN

14.7.5. Australia & New Zealand

14.7.6. Rest of Asia-Pacific

14.8. Asia Pacific Contrast Media Agents Market – Opportunity Analysis Index, By Product Type, By Modality, By Route of Administration, By Disease Indication, By Application, By End User, and Country, 2019 – 2025

14.9. Asia Pacific Contrast Media Agents Market Dynamics – Trends

15. Latin America Contrast Media Agents Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

15.1. Product Type Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

15.1.1. Barium-based Contrast Media

15.1.2. Iodinated Contrast Media

15.1.3. Gadolinium-based Contrast Media

15.1.4. Microbubble Contrast Media

15.2. Modality Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

15.2.1. X-Ray

15.2.2. CT-Scan

15.2.3. Magnetic Resonance Imaging (MRI)

15.2.4. Ultrasound

15.2.5. Others

15.3. Route of Administration Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

15.3.1. Oral

15.3.2. Injectable

15.3.3. Rectal

15.3.4. Urethral

15.3.5. Others

15.4. Disease Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

15.4.1. Musculoskeletal Disorders

15.4.2. Neurological Disorders

15.4.3. Nephrological Disorders

15.4.4. Cardiovascular Disorders

15.4.5. Oncology

15.4.6. Gastrointestinal Disorders

15.5. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

15.5.1. Radiology

15.5.2. Interventional Radiology

15.5.3. Interventional Cardiology

15.6. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

15.6.1. Hospitals

15.6.2. Clinics

15.6.3. Diagnostic Centers

15.6.4. Others

15.7. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

15.7.1. Mexico

15.7.2. Brazil

15.7.3. Argentina

15.7.4. Venezuela

15.7.5. Rest of Latin America

15.8. Latin America Contrast Media Agents Market – Opportunity Analysis Index, By Product Type, By Modality, By Route of Administration, By Disease Indication, By Application, By End User, and Country, 2019 – 2025

15.9. Latin America Contrast Media Agents Market Dynamics – Trends

16. Middle East and Africa Contrast Media Agents Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025

16.1. Product Type Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

16.1.1. Barium-based Contrast Media

16.1.2. Iodinated Contrast Media

16.1.3. Gadolinium-based Contrast Media

16.1.4. Microbubble Contrast Media

16.2. Modality Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

16.2.1. X-Ray

16.2.2. CT-Scan

16.2.3. Magnetic Resonance Imaging (MRI)

16.2.4. Ultrasound

16.2.5. Others

16.3. Route of Administration Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

16.3.1. Oral

16.3.2. Injectable

16.3.3. Rectal

16.3.4. Urethral

16.3.5. Others

16.4. Disease Indication Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

16.4.1. Musculoskeletal Disorders

16.4.2. Neurological Disorders

16.4.3. Nephrological Disorders

16.4.4. Cardiovascular Disorders

16.4.5. Oncology

16.4.6. Gastrointestinal Disorders

16.5. Application Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

16.5.1. Radiology

16.5.2. Interventional Radiology

16.5.3. Interventional Cardiology

16.6. End User Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

16.6.1. Hospitals

16.6.2. Clinics

16.6.3. Diagnostic Centers

16.6.4. Others

16.7. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

16.7.1. GCC Countries

16.7.2. South Africa

16.7.3. Israel

16.7.4. Rest of MEA

16.8. Middle East and Africa Contrast Media Agents Market – Opportunity Analysis Index, By Product Type, By Modality, By Route of Administration, By Disease Indication, By Application, By End User, and Country, 2019 – 2025

16.9. Middle East and Africa Contrast Media Agents Market Dynamics – Trends

17. Competition Landscape

17.1. Strategic Dashboard of Top Market Players

17.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)

17.2.1. GE Healthcare (US)

17.2.2. Bracco Imaging (Italy)

17.2.3. Bayer HealthCare (Germany)

17.2.4. Guerbet (France)

17.2.5. Lantheus (US)

17.2.6. Daiichi Sankyo (Japan)

17.2.7. Unijules Life Sciences (India)

17.2.8. J.B. Chemicals and Pharmaceuticals (India)

17.2.9. Spago Nanomedicine (Sweden)

17.2.10. Taejoon Pharm (South Korea)

17.2.11. Jodas (India)

17.2.12. Magnus Health (India)

18. Research Methodology

19. Key Assumptions and Acronyms

Description

search

Contrast Media Agents Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Description

Contrast Media Agents Market

Contrast Media Agents Market

Features of the Report

Product-Application

Modality-End-User

Route-Administration

Disease-Indication

GEOGRAPHY

Frequently Asked Questions

Table Of Content

Company Profile

Description

Product categories

Our Clients

ASIA PACIFIC OFFICE

EUROPE OFFICE